Seizure control following radiotherapy in patients with diffuse gliomas: A retrospective study

Neuro-Oncology

Volumn 15, Issue 12, 2013, Pages 1739-1749

  Rudá, Roberta ^a   Magliola, Umberto ^a   Bertero, Luca ^a   Trevisan, Elisa ^a   Bosa, Chiara ^a   Mantovani, Cristina ^a   Ricardi, Umberto ^a   Castiglione, Anna ^b   Monagheddu, Chiara ^b   Soffietti, Riccardo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b AOCittádella Salute e della Scienza di Torino ^*  (Italy)

Author keywords

Diffuse gliomas; Radiotherapy; Seizure control

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; LOMUSTINE; OXCARBAZEPINE; PHENOBARBITAL; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; ARTICLE; ASTROCYTOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; DISEASE CONTROL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INTRACTABLE EPILEPSY; MALE; MIDDLE AGED; MONOTHERAPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; OUTCOME ASSESSMENT; RADIATION DOSE; RADIATION INDUCED EMESIS; RADIATION INJURY; RETROSPECTIVE STUDY; SEIZURE CONTROL; SIMPLE PARTIAL SEIZURE; TONIC CLONIC SEIZURE; TUMOR GROWTH; YOUNG ADULT;

DIFFUSE GLIOMAS; RADIOTHERAPY; SEIZURE CONTROL;

ADULT; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SEIZURES; YOUNG ADULT;

EID: 84891862733     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not109     Document Type: Article

References (37)

1. van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6:421-430.
2. Smits A, Duffau H. Seizures and the natural history of World Health Organizationgrade II gliomas: A review.Neurosurgery. 2011;68:1326-1333.
3. You G, Sha ZY, YanW, et al. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: A clinicopathological study. Neuro Oncol. 2012;14:230-241.
4. Duffau H, Capelle L, Lopes M, et al. Medically intractable epilepsy from insular low-grade gliomas: improvement after an extended lesionectomy. Acta Neurochir. 2002;144:563-572.
5. ZaatrehMM,Firlik KS, Spencer DD, et al. Temporal lobe tumoral epilepsy: characteristics and predictors of surgical outcome. Neurology. 2003;61: 636-641.
6. Chang EF, Potts MB, Keles GE, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008;108:227-235.
7. Englot DJ, Berger MS, Barbaro NM, et al. Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg. 2011;115:240-244.
8. Hildebrand J, Lecaille C, Perennes J, et al. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology. 2005;65:212-215.
9. Rudá R, Trevisan E, Soffietti R. Epilepsy and brain tumors. Curr Opin Oncol. 2010;22:611-620.
10. Klein M, Engelberts NH, van der Ploeg HM, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003;54:514-520.
11. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159-168.
12. Scerrati M, Montemaggi P, Iacoangeli M, et al. Interstitial brachytherapy for low-grade cerebral gliomas: Analysis of results in a series of 36 cases. Acta Neurochir. 1994;131:97-105.
13. Warnke PC, Berlis A,Weyerbrock A, et al. Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low-grade gliomas. Acta Neurochir. 1997;68:90-92.
14. Schröttner O, Unger F, Eder HG, et al. Gamma-Knife radiosurgery of mesiotemporal tumour epilepsy observations and long-term results. Acta Neurochir. 2002;84:49-55.
15. Rogers LR, Morris HH, Lupica K. Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology. 1993;43:1599-1601.
16. Chalifoux R, Elisevich K. Effect of ionizing radiation on partial seizures attributable to malignant cerebral tumors. Stereotact Funct Neurosurg. 1997;67:169-182.
17. van den Bent MJ, Afra D, de Witte O, et al. EORTCradiotherapy and brain tumor groups and the UK Medical Research Council. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005;366:985-990.
18. Kahlenberg CA, Fadul CE, RobertsDW, et al. Seizure prognosis of patients with low-grade tumors. Seizure. 2012;21:540-545.
19. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1 p deletions. J Clin Oncol. 2004;22:3133-3138.
20. Kaloshi G, Benouaich-Amiel A, Diakite F, et al. Temozolomide for lowgrade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology. 2007;68:1831-1836.
21. Engel JJ, Van Ness PC, Rasmussen TB, et al. Outcome with respect to epileptic seizures. In: Engels, JJ, ed. Surgical Treatment of the Epilepsies, 2nd ed. New York: Raven Press; 1993:609-621.
22. Bauman G, Pahapill P, Macdonald D, et al. Lowgrade glioma: A measuring radiographic response to radiotherapy. Can J Neurol Sci. 1999;26:18-22.
23. Pallud J, Llitjos JF, Dhermain F, et al. Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol. 2012;14:496-505.
24. Mason WP, Krol GS, DeAngelis LM. Low-grade oligodendroglioma responds to chemotherapy. Neurology. 1996;46:203-207.
25. Soffietti R, Rudà R, Bradac GB, et al. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery. 1998;43: 1066-1073.
26. Brada M, Viviers L, Abson C, et al. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol. 2003;14:1715-1721.
27. Pace A, Vidiri A, Galiè E, et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol. 2003;14:1722- 726.
28. Lebrun C, Fontaine D, BourgV, et al. Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. Eur J Neurol. 2007;14:391-398.
29. Taillandier L, Duffau H. Epilepsy and insular grade II gliomas: An interdisciplinary point of view from a retrospectivemonocentric series of 46 cases. Neurosurg Focus. 2009;27:E8.
30. Sherman JH, Moldovan K, Yeoh HK, et al. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg. 2011;114:1617-1621.
31. Ricard D, Kaloshi G, Amiel-Benouaich A, et al. Dynamic history of lowgrade gliomas before and after temozolomide treatment. Ann Neurol. 2007;61:484-490.
32. Peyre M, Cartalat-Carel S, Meyronet D, et al. Prolonged response without prolonged chemotherapy: A lesson from PCV chemotherapy in low-grade gliomas. Neuro Oncol. 2010;12:1078-1082.
33. Kiebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: Results of a randomized phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer. 1998;34:1902-1909.
34. Wick W, Hartmann C, Engel C, et al. NOA-04 randomized phase III trial of sequential radiochemotherapyofanaplastic gliomawith procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol. 2009;27:5874-5880.
35. van den Bent MJ, Wefel JS, Schiff D, et al. Response assessment in neuro-oncology (a report of the RANO group): Assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol. 2011;12:583-593.
36. Aaronson NK, Taphoorn MJ, Heimans JJ, et al. Compromised healthrelated quality of life in patients with low-grade glioma. J Clin Oncol. 2011;29:4430-4435.
37. Rudà R, Bello L, Duffau H, Soffietti R. Seizures in low-grade gliomas: natural history, pathogenesis and outcome after treatments. Neuro Oncol. 2012;14:iv55-iv64.